ORIGINAL RESEARCH article
Front. Nutr.
Sec. Clinical Nutrition
This article is part of the Research TopicNutrition in Cancer Patients Undergoing Targeted Therapy: From Mechanisms to Clinical PracticeView all 12 articles
Impact of Prognostic Nutritional Index and Geriatric Nutritional Risk Index on Prognosis in Elderly Patients with Early-Stage Prostate Cancer
Provisionally accepted
PINAR PEKER1*
ASLI GEÇGEL2
Oğuzcan Özkan3serdar yılmaz1seher selvi1cafer cırık1sezen koca1
ALPAY DÜŞGÜN1burcu arslan benli1BERNA BOZKURT DUMAN1TİMUÇİN ÇİL1- 1Adana City Training and Research Hospital, Ministry of Health (Turkey), Adana, Türkiye
- 2TC Saglik Bakanligi Yozgat Sehir Hastanesi, Yozgat, Türkiye
- 3TC Saglik Bakanligi Usak Egitim ve Arastirma Hastanesi, Usak, Türkiye
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Aim: Prostate cancer predominantly affects older men and generally has a favorable early-stage prognosis, yet the prognostic significance of nutritional and inflammatory status remains uncertain. This study evaluated the prognostic value of the Prognostic Nutritional Index (PNI) and Geriatric Nutritional Risk Index (GNRI) in elderly patients with localized prostate cancer. Methods: This single-center retrospective cohort study included 205 patients aged ≥65 years with early-stage prostate cancer treated between 2018 and 2024. Nutritional status was assessed at baseline using serum albumin, lymphocyte count, and body weight to calculate the PNI and GNRI. Overall survival was analyzed using standard survival analysis methods. All statistical analyses were performed using SPSS software version 26.0. Results: The median patient age was 72 years. Of all patients, 41% were 75 years or older. Survival analysis showed that patients with low PNI had a median OS of 78 months. Those with high PNI had a median OS of 115 months (p = 0.008). Low GNRI was linked to a median survival of 74 months. High GNRI was linked to 120 months (p = 0.009). Higher Gleason score (≥8), higher PSA (≥10 ng/mL), older age (≥75 years), and clinical T2 disease were associated with worse outcomes. By contrast, radiotherapy improved survival (122 vs. 94 months, p = 0.008). In multivariate analysis, low PNI, low GNRI, high Gleason score, and high PSA remained independent predictors. Conclusions: The PNI and GNRI serve as practical and accessible indicators of nutritional status and inflammation, thereby improving prognostic assessment and risk stratification in older patients with early-stage prostate cancer.
Keywords: early-stage prostate cancer, elderly patients, Geriatric Nutritional Risk Index, Prognostic Nutrition Index, survival analysis
Received: 13 Nov 2025; Accepted: 26 Jan 2026.
Copyright: © 2026 PEKER, GEÇGEL, Özkan, yılmaz, selvi, cırık, koca, DÜŞGÜN, benli, BOZKURT DUMAN and ÇİL. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: PINAR PEKER
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.